Logo of jester cap with thought bubble.

Image source: The Motley Fool.

Insperity Inc (NSP 0.68%)
Q3 2019 Earnings Call
Nov 4, 2019, 9:00 a.m. ET

Contents:

  • Prepared Remarks
  • Questions and Answers
  • Call Participants

Prepared Remarks:

Operator

Good morning. My name is Marcella, and I will be your conference operator today. I would like to welcome everyone to the Insperity Third Quarter 2019 Earnings Conference Call. At this time, all participants are in listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions]

At this time, I would like to introduce today's speakers. Joining us are Paul Sarvadi, Chairman of the Board and Chief Executive Officer, and Douglas Sharp, Senior Vice President of Finance, Chief Financial Officer and Treasurer.

At this time, I'd like to turn the call over to Douglas Sharp. Mr. Sharp, please go ahead.

Douglas S. Sharp -- Senior Vice President-Finance, Chief Financial Officer and Treasurer

Thank you.

We appreciate you joining us this morning. Let me begin by outlining our plan for this morning's call. First, Paul is going to discuss our third quarter results and how we are positioned for growth as we head into 2020. I will then discuss further details behind Q3 results and in particular focus on our healthcare costs. I will also provide our updated full year 2019 guidance and provide high level comments on our gross profit outlook for 2020. We will then end the call with a question-and-answer session.

Before we begin, I would like to remind you that Mr. Sarvadi or myself may make forward-looking statements during today's call which are subject to risks, uncertainties and assumptions. In addition, some of our discussion may include non-GAAP financial measures. For a more detailed discussion of the risks and uncertainties that could cause actual results to differ materially from any forward-looking statements and reconciliations of non-GAAP financial measures, please see the Company's public filings, including the Form 8-K filed today, which are available on our website.

Now at this time, I'd like to turn the call over to Paul.

Paul J. Sarvadi -- Management Director, Chairman and Chief Executive Officer

Thanks, Doug, and thank you, all, for joining us.

Our reported results today include a year-to-date increase in revenues, up 13%, net income up 18% and EPS up 21% over 2018. These numbers would be considered solid for most companies. However, they're not commensurate with our outstanding performance over the last five years. These results include third quarter performance below our expectations, driven primarily by a second consecutive quarter with elevated large claims in our medical plan and, to a small degree, by lower growth than expected in paid worksite employees. Doug and I will explain exactly what happened and what this means to our going-forward plan.

The bottom line conclusion from our analysis of the drivers of our recent results indicate our growth plan remains solid and we expect to maintain our industry-leading double digit unit growth into 2020. And, we believe we do not have a systemic issue in our medical plan that would compound into next year.

I'll begin with a discussion of our growth drivers and how we arrive at our expectations going forward. I'll also highlight results from a recent client survey in the traction we're gaining on our traditional employment solutions bundle Workforce Acceleration. Doug will follow with comments about the recent quarter, including specifics regarding our medical plan and provide updated guidance for the year.

We began 2019 with an expectation for growth in paid worksite employees of 15% based upon our starting point in January and our budget for each of the three growth drivers, including new sales, client retention and growth in the client base. We now expect in the year a 13% growth in paid worksite employees. Approximately half of this shortfall is due to lower growth and the net change in our client base and the other half due to fewer worksite employees paid from new sales from what we budgeted and forecasted as the year played out. Client retention has been and is expected to be substantially on plan, continuing near historic highs.

In the second and third quarters we were surprised by the lower than expected net change in existing employees within the client base in the last month of each quarter. As we mentioned last quarter, we had substantially fewer seasonal full time employees added in June compared to previous years. Since we had substantially fewer adds in June we expected substantially fewer departures in September. Although we were correct conceptually, we were off in magnitude and experienced a shortfall from our forecast in September.

In the bigger picture, our client base remains optimistic about their businesses and our continuing efforts to hire accordingly. The tight labor market has made it more difficult to find employees, making net gains in the client base less predictable. However, in this environment, our HR services become even more valuable to clients and prospects, which is a plus for retention and sales.

Our paid worksite employee number from new sales explains the other half of the shortfall. Although we were substantially on plan in this metric through two quarters, the last two months of Q3 fell behind. The primary cause leading to fewer paid worksite employees from sales in Q3 is we simply have too few trained BPAs early this year and did not offset that with mid-market sales. Both of these issues have rebounded and now point toward strong performance in the fall campaign and as we look ahead to 2020. Historically, our unit growth follows the growth rate in the number of trained Business Performance Advisors with an approximately two quarter lag as new trained sales personnel gain efficiency. Mid-market results either add or subtract from that core growth rate.

We ended the third quarter with a 13% increase in trained BPAs, up from 10% in Q1, and our fall campaign sales activity reflects this momentum. Sales for the first month of the campaign were 103% of budget and the number of business profiles or opportunities to bid to our workforce optimization services is up 23% over last year. Our success in mid-market sales last year indicated we could see continuing leverage in sales in 2019, allowing for unit growth at a faster rate than our growth in our BPA team.

This year we have nearly the same number of accounts sold year-to-date in our mid-market segment and a substantially larger pipeline for 2020. However, the biggest difference from last year in mid-market sales is the lower average size of accounts sold and the fact that we did not close a large enterprise account like we did last year. Last year on July 1, we enrolled our largest account ever. This added 160 basis points to our unit growth rate last fall. Since we did not repeat that large sale or increase the number of mid-market sales, year-over-year comparisons beginning in July this year is difficult. This is exaggerating the quarterly slowdown in unit growth over this year from mid double digits to low double digits.

As we look ahead to 2020, the number of trained BPAs will drive our unit growth and mid-market sales will supplement that growth. In retrospect, I believe I was too optimistic in expecting mid-market sales to offset a lower growth rate in BPAs at this stage. With this plan in place, we should see quarterly growth acceleration over 2020, especially as we move past the difficult comparisons related to the large mid-market account.

One other initiative we took when the third quarter ended was a comprehensive survey of our client base to analyze recent client business and hiring activity and determine their outlook for 2020. We designed this survey to provide further insight in our budgeting and forecasting. We generally found the health of this small business community strong and the outlook for 2020 to be better than 2019.

Keep in mind, small business owners are an optimistic lot, but we also found this to be consistent with the economic indicators we monitor in our client base. Over time, as a percentage of base pay, it was over 11%; average pay up over 4%; and commissions paid to the sales staff of our clients up over 8%. The survey, which will be released tomorrow, also found the ability to hire and retain employees and driving revenue to be the number one or two concern for all segments except our largest clients where controlling operating cost edged out hiring and retaining employees.

I would also like to mention the excellent progress we made in Q3 gaining traction in our traditional employment strategy, selling our Workforce Acceleration bundle, which is a critical success factor in our current five-year plan. Our goal for this year has been to extend the adoption of this strategy across our BPA team throughout the country. This strategy includes introducing both co-employment and traditional employment bundled HR solutions early in the sales process. We typically sell one out of 10 of our small to medium-sized business prospects on our flagship Workforce Optimization co-employment bundle. Our traditional employment strategy is to ultimately convert some percentage of the nine out of 10 that either don't qualify or not ready for workforce optimization to our Workforce Acceleration option.

This quarter, we gained significant traction, coming in at 123% of our budget and reaching 5,000 employees sold in traditional employment solutions. Success in this traditional employment bundled HR solution has a tremendous effect on our business model. These sales represent a value to Insperity of about one-third compared to Workforce Optimization clients without the benefit plan risk and contribute to improving gross profit. These clients also represent an opportunity to up-sell to the full co-employment service at a later date, improving overall sales efficiency.

So in summary, we have been on a tremendous run the last five years with a double-digit growth rate in paid worksite employees within our targeted range of 10% to 15%, driven by growth in the number of BPAs plus or minus mid-market account effects. We expect to continue this growth plan into 2020 and enhance our business model with improving Workforce Acceleration results.

At this time, I'd like to pass the call back to Doug.

Douglas S. Sharp -- Senior Vice President-Finance, Chief Financial Officer and Treasurer

Thanks, Paul.

Now let me begin by discussing further details of our third quarter results. Average paid worksite employees increased 12% over Q3 of 2018, with a sequential increase of 4% over Q2 of this year. Higher than expected benefit costs resulted in just a 3% increase in gross profit over the third quarter of 2018. These higher benefit costs of approximately $18 million were slightly offset by favorable results in other areas of gross profit and operating costs, but drove the decline in adjusted EBITDA to $51 million and adjusted EPS to $0.75.

Now, upon receipt of our third quarter healthcare claims data in October and our subsequent analysis of this data, we determined that these higher benefit costs were primarily driven by elevated large claim activity, which declined from Q2 but did not return to historical levels. Two consecutive quarters of large healthcare claim payments at these elevated levels is a historical anomaly for us.

Additionally, we have historically had a strong track record in predicting our total claim costs on an annual basis. It appears that 2019 will be an exception due to this recent spike in large claims. In light of this, we have spent an extensive amount of time drilling into the details of claims data with the assistance of our insurance carrier in order to determine the root cause of the elevated claims and whether anything systemic has changed in our plan. Based upon our review of the detailed data, we have determined the following.

First, it's clear that only a relatively small number of claimants, rather than something pervasive over our entire participant base, negatively impacted our healthcare costs in Q2 and Q3. An analysis of large claims over the past two years indicated a recent spike in activity related to participants with clients exceeding $250,000 a year. These jumbo claims from a very small number of participants were the primary driver behind our claim dollars exceeding expectations by approximately $27 million over the past two quarters.

As a second finding, our insurance carrier confirmed that there was an element of randomness in the recent elevated large claim activity and there was an expectation that it would revert back to a normal level. The recent increase in the frequency of claimants with jumbo claims is above the level of our insurance carriers' fully insured book of business, whereas prior to this activity we have historically been in line or below their book.

Thirdly, an analysis of claims over $100,000 over the course of the two quarters shows that the claims were largely from different participants as opposed to ongoing claims from the same group of participants. The fact that the two consecutive quarters of large claim activity were driven by two largely different groups of participants further points to the randomness of these two isolated events.

Fourthly, a review of the clients associated with these large claims did not indicate a concentration associated with new clients and therefore would indicate that this was not driven by adverse client selection.

And finally, our comprehensive review of overall plan participant demographics such as age, gender, geographic mix, overall inpatient hospital stays and plan migration continues to point to favorable trends of our health plan as a whole. Accordingly, based upon our detailed review our best estimate is that the spike in large claim activity during 2019 is a historical anomaly and we expect the large claim activity to normalize.

Now, even though the claims data doesn't appear to point to an ongoing issue with our health plan, we believe it is prudent to take a more conservative approach to estimating benefit costs for the fourth quarter by not assuming a further reduction in large claim levels for the remainder of 2019. And when taking a look at the full year, you may recall that we began 2019 estimating an expected benefit cost trend of 2% to 3% over 2018. Year-to-date results, combined with our revised Q4 forecast, yields a cost trend of approximately 3.7% which is still favorable to trends seen in the marketplace. The elevated large claim activity fully accounts for the incremental trend over the midpoint of our initial budget. As we look forward to 2020 and enter a new plan year, our detailed claims data does not indicate the level of large claim activity will compound by increasing over the recent elevated rate. Under this scenario, we would expect 2020 to return to a more normalized benefit-cost trend over 2019 costs and we are pricing our new and renewing business accordingly.

Considerable pricing strength throughout 2019 in other areas of gross profit, combined with favorable cost trends in our other direct cost areas and the traction we are gaining in Workforce Acceleration, contributes to our outlook for gross profit improvement in 2020. And any reversion of large claim activity back to our lower levels would reduce our 2020 benefit cost trend and further improve our gross profit.

Now shifting to our balance sheet and cash flow. We ended the second [Phonetic] quarter with $131 million of adjusted cash and $239 million of debt outstanding on our recently expanded $500 million credit line. We have now repurchased 1.5 million shares in 2019, including 1.2 million shares in Q3. When combined with dividend payments totaling $37 million, we have returned just over $190 million to shareholders thus far in 2019 as we continue to invest in the long-term growth of the business.

Now, before we open up the call for questions, I'd like to provide an update to our full year 2019 forecast. As Paul just mentioned, we are now forecasting 13% growth in average paid worksite employees for the full year 2019. Our updated 2019 earnings guidance takes into account this revised growth forecast, the recent elevated large claim activity and our conservative approach to estimating Q4 benefit costs. With this in mind, we are now forecasting full year 2019 adjusted EPS in a range of $4.08 to $4.20 and adjusted EBITDA in a range of $247 million to $253 billion.

While we are obviously disappointed in the effect of elevated healthcare costs in our 2019 results, we still plan on completing the year with both an industry-leading worksite employee growth rate and profitability per worksite employee. We are currently going through our normal budgeting process for 2020 and will provide our detailed guidance on our next earnings call. Based upon our current outlook including our earlier comments in the areas of worksite employee growth in gross profit, we expect 2020 earnings growth to be improved and not indicative of the latter half of 2019.

Now at this time, I'd like to open up the call for questions.

Questions and Answers:

Operator

[Operator Instructions] Your first question comes from the line of Tobey Sommer from SunTrust. Your line is open.

Jasper Bibb -- SunTrust Robinson Humphrey -- Analyst

Thanks. This is Jasper Bibb on for Tobey today. With respect to the guide for WSE growth, could you quantify how much of that comes from additional hiring within the existing customer base? And are there any trends you're seeing on that?

Paul J. Sarvadi -- Management Director, Chairman and Chief Executive Officer

Yeah. I mean, we've taken a conservative look at the net gain from employees based on kind of what's going on the last couple of quarters. But like I said about the survey we conducted, there's still a lot of optimism out there. People have generally met their business plans for the year and are looking at improve sales for next year. And so we expect the need for employees within our client base to continue, and to the degree that you can find the qualified people, they will continue to see growth in the client base. But we're kind of being conservative about that going forward.

Jasper Bibb -- SunTrust Robinson Humphrey -- Analyst

Okay, perfect. I was wondering if you could elaborate on those changes to your healthcare pricing after seeing those outsized claims in the past few quarters.

Paul J. Sarvadi -- Management Director, Chairman and Chief Executive Officer

Yeah. So, on the pricing side we have an ongoing process where we are pricing every new and renewing customer every month based on the most recent information that we have. So we've been continuing to move pricing up accordingly. Of course, at the year-end we also have our year-end transition where you have the highest number of new clients coming in from new sales and you have the highest churn from the turnover of clients at year-end as well because a high percentage are on annual contracts that line up with the year-end.

But we feel very good. Pricing has been strong throughout the year and has even come in ahead of our expectations as the year went along. So we feel good about the -- how we have things priced going forward even in spite of this anomaly we've had on these large claims.

Jasper Bibb -- SunTrust Robinson Humphrey -- Analyst

Okay. Great. Last question from me. I was curious if you could update us on people analytics and how important that is to how you think about mid-market growth heading into 2020.

Paul J. Sarvadi -- Management Director, Chairman and Chief Executive Officer

Yes. I've considered putting that in my prepared remarks, but we want to get to the point of some of the bigger things that were happening. But we're really excited about the analytics engine that we've built into Insperity Premier, and we're now I believe over half of our mid-market clients have had a in-depth discussion about the analytics engine and how it -- and the data and information, the instant insights that it provides. And we really believe that this allows us -- this tool allows us to really emphasize what I call our software with a service differentiation, the advantage we bring to the table by not only bringing instant infrastructure but now instant insights.

And as soon as you have an insight you want to know what to do about it. So the fact that Insperity comes not only with the technology, but with the professionals that are able to help devise a game plan to take that insight and turn it into results for our client, that makes what we do for our customers very unique, and I especially think it's going to be very prominent in our midmarket space.

Jasper Bibb -- SunTrust Robinson Humphrey -- Analyst

That's helpful. Thanks, guys.

Operator

Your next question comes from the line of Jim Macdonald from First Analysis. Your line is open.

Jim Macdonald -- First Analysis -- Analyst

Yeah. Good morning, guys.

Paul J. Sarvadi -- Management Director, Chairman and Chief Executive Officer

Good morning.

Jim Macdonald -- First Analysis -- Analyst

You haven't talked about how your -- how you came to your guidance for worksite employees for Q4, which also seems way below what we would have expected. I mean, you had pretty strong commission activity in Q3. So what's causing the big drop in worksite employee guidance [Indecipherable] basically doubling the miss from this quarter?

Paul J. Sarvadi -- Management Director, Chairman and Chief Executive Officer

Well, Jim, you can -- as you know, the sales that you make this time of the year generally come in in January and we took that out -- kind of most of the net gain from existing -- you don't have a lot of clients terming or -- from the retention side, we expect it to be the same. But we just want to be really conservative about it and -- at this point, frankly that fourth quarter doesn't really matter. We're all focused on the January starting point for the year.

And so what we're really focused on is our fall campaign activity, and we've got our nice increase in trained rep count back up where it belongs, 13%. We've got our key indicator for sales activity which is the number of opportunities to bid running really strong over the -- even over the growth rate at 123% for the beginning of the campaign.

So we think we're off to a really good start. We know we're off to a really good start. And as we maintain that, then we'll get into next year and see a more normalized pattern for growth. So we're in that period where you have this year-over-year growth on top of this significant increase in the -- with the large customer we had last year. And with that comparable, along with having a lower trained BPA count early in the year -- that's just the way it's come out at this point -- we're focused on turning that around.

Jim Macdonald -- First Analysis -- Analyst

Can you give us the current or end of quarter trained BPA level?

Paul J. Sarvadi -- Management Director, Chairman and Chief Executive Officer

Yeah. Let's -- in here -- in a second here. [Indecipherable] Just under -- 548.

Jim Macdonald -- First Analysis -- Analyst

At the end of quarter?

Paul J. Sarvadi -- Management Director, Chairman and Chief Executive Officer

Right.

Jim Macdonald -- First Analysis -- Analyst

Okay. And over to healthcare. So, I hear your survey results and things, but what if employees were thinking -- I don't know if you surveyed employees are the employers. But if employees are worried about their jobs for some reason, would this kind of healthcare activity, would that be more normal if everyone was sort of worried about their jobs or thinking about leaving their jobs or worried about being fired?

Paul J. Sarvadi -- Management Director, Chairman and Chief Executive Officer

Not really, Jim. I mean, I wouldn't see any connection between -- first of all, if they are worried about their employment which -- the labor market is so strong -- I don't see that right now. But if they were, I don't see how that would drive a large claim debt which was the core issue here, these jumbo claims above $250,000. We just had a significant increase in the incident rate and -- we will -- it's sitting down with our insurance carrier going to -- you can't believe how much data we went to looking at it every six ways from Sunday, and the answer is the same every time and it's these random large claims.

In our history, we've had large claims in the quarter. All of our investors usually know that. That happens once in a while. Usually we haven't even seen happen more than once in a year like that, and that's why it kind of evened out over the course of the year. This is two quarters in a row. It's more the luck of the draw and it's very disappointing, but it's what happened. There is nothing systemic in the plan, and I really don't see it being driven by employee-related activity.

Douglas S. Sharp -- Senior Vice President-Finance, Chief Financial Officer and Treasurer

Yeah. Jim, it's Doug. We also looked at the nature of the large claim activity, and the two big drivers to it were heart conditions -- heart attack, issues like that, and cancer treatments, which clearly then point to your earlier question there -- and to some lesser extent, accidents even, within the participant base. So it gives you a little bit of flavor there as to the drivers, and gives you -- hopefully it helps you out there also on your question.

Paul J. Sarvadi -- Management Director, Chairman and Chief Executive Officer

Yeah. None of those are what you'd call chronic in terms of -- the treatment period is a specific thing, and then you go down the road.

Operator

Thanks. Your next question comes from the line of Jeff Martin from Roth Capital. Your line is open.

Jeff Martin -- Roth Capital Partners -- Analyst

Thanks. Good morning, guys.

Paul J. Sarvadi -- Management Director, Chairman and Chief Executive Officer

Good morning, Jeff.

Jeff Martin -- Roth Capital Partners -- Analyst

Wanted to get a sense on how you feel that the higher benefits cost could affect your year-end transition in terms of retention.

Paul J. Sarvadi -- Management Director, Chairman and Chief Executive Officer

Really no connection there because our pricing strategy really -- this didn't call for any change in pricing. Remember, the total cost trend of 3.7% that we even have in this year is really favorable against the market at large as it is. Our normal pricing strategy would actually have us pricing in a higher number than that in our normal pricing.

However, that number gets offset by people making plan design changes or choosing a lower cost plan or making other changes where it's not -- we can't really determine today what percentage increase where we have a benefits pricing in January but -- but we know we've built in a higher number than the 3.7%. It will come out something lower than that, but it will be within the range and we don't have a cost price mismatch. We don't have to go back and hurry up and increase prices on customers. That's not what's going on from this situation.

Jeff Martin -- Roth Capital Partners -- Analyst

Okay. And then, is this the first time that you've really seen claims come in above your fully insured book of business? I know here you mentioned historically it's in line or below. But is this really the first time you've seen that trend?

Paul J. Sarvadi -- Management Director, Chairman and Chief Executive Officer

I would say without having the benefit of going back and look at every quarter, historically, but certainly we don't know over time -- I mean, our whole book of business constantly runs better than United's book. They tell us that on an ongoing basis. The comments in our script related to these large claims, which, for this period, for the first time ran above their level, and that's historically been below.

We don't have any reason while we're sitting here today to think they're not going to turn back to at least the normalized levels, and frankly I don't have any reason to think -- based on how we run the plan, we did a complete deep dive on the demographics to see if there's anything driving this, any source of new business, any -- any age, gender differences, any selection that could possibly be driving this, and it's just not there.

In fact, the demographic review -- that's a 50-something page analysis -- actually shows our book of business, measured in terms of the health of the book and how it changes, actually was a little positive. So that's -- again confirm nothing there driving these two quarters we had.

Jeff Martin -- Roth Capital Partners -- Analyst

Okay. That's all from me. Thank you, guys.

Paul J. Sarvadi -- Management Director, Chairman and Chief Executive Officer

Thank you.

Operator

[Operator Instructions] Your next comes from the line of Mark Marcon from Baird. Your line is open.

Mark Marcon -- Robert W. Baird & Co. -- Analyst

Good morning, guys.

Paul J. Sarvadi -- Management Director, Chairman and Chief Executive Officer

Good morning, Mark.

Mark Marcon -- Robert W. Baird & Co. -- Analyst

When did you -- you bought back a lot of stock this quarter. When did you it buy back?

Paul J. Sarvadi -- Management Director, Chairman and Chief Executive Officer

Let's see here, Mark. I mean, it's throughout the quarter. I mean, we followed our normal pattern here, which is to buy in the open market when we can and then put in a 10b5-1 plan when we are going into the quiet period.

Douglas S. Sharp -- Senior Vice President-Finance, Chief Financial Officer and Treasurer

Yeah. But it was really -- yeah throughout the entire quarter.

Mark Marcon -- Robert W. Baird & Co. -- Analyst

When did you discover that the healthcare costs were running at an elevated level?

Paul J. Sarvadi -- Management Director, Chairman and Chief Executive Officer

Well, as I mentioned in my prepared remarks, as with every quarter, we get the claims from -- data from United Healthcare, and that's month following the end of the quarter. And so it was in October. First, we get the initial claims data from them, and then we a week further -- it takes time to further analyze that data and in particularly in a quarter like this, where you can keep going into a deeper analysis of that, but that's very -- that's typical with every quarter over the course of our history. So you don't know your healthcare claims data on an incurred basis until after the quarter is over with.

Mark Marcon -- Robert W. Baird & Co. -- Analyst

Is there the possibility of getting more frequent updates?

Paul J. Sarvadi -- Management Director, Chairman and Chief Executive Officer

It's actually not a matter of frequent updates. We meet with United every month. And even through the September meeting, there wasn't an indication because you don't have the quarterly report, which has the fully in -- full claims as on an incurred basis put back to where they initiated. And things were looking reasonable at -- through the two months, and not until the claim reports for the quarter that came in after, that we were faced with some numbers that were quite disappointing.

Mark Marcon -- Robert W. Baird & Co. -- Analyst

Yeah. The point is, I'm assuming you wouldn't have bought 1.2 million shares if you had known that this was going to transpire.

Paul J. Sarvadi -- Management Director, Chairman and Chief Executive Officer

That's exactly correct.

Douglas S. Sharp -- Senior Vice President-Finance, Chief Financial Officer and Treasurer

It's a safe assumption.

Mark Marcon -- Robert W. Baird & Co. -- Analyst

So, I guess the question is, is there a way to get an earlier warning system, any sort of rolling system or anything like that?

Paul J. Sarvadi -- Management Director, Chairman and Chief Executive Officer

So what we've done because of this large claim activity, we did work with our carrier to provide various looks at various cuts of these sizes, and looking at some projection of ongoing cost. At this point we have some things that we will probably work with them on to try to get better insight. But now that it's kind of new information, it's not something we're going to be able to say right away this will help us project that. So we're going to continue to work with them and try to get more information earlier, but it will take a little time to see if there is really anything in there that can do that.

The problem is on these jumbo type claims, the carrier gets some when they finally get filed, and sometimes it's -- I mean, you can run through a process -- they're monitoring conditions, and though things are happening. And -- you always have some number of them. You just -- when are you going to have an increase like this? This is really outside the norm to have this higher an incident rate and those jumbo claims in such a short period of time and that's the bottom line.

Operator

Your next question comes from the line of Jim Macdonald from First Analysis. Your line is open.

Jim Macdonald -- First Analysis -- Analyst

Yeah, I just wanted to follow up on what you're seeing in the market in terms of rate increases. We've been hearing of some -- for healthcare -- we've been hearing some pretty high numbers out there actually this year.

Paul J. Sarvadi -- Management Director, Chairman and Chief Executive Officer

Yeah. As far as within the marketplace at large, I think from our carrier's perspective I think you're looking at high-single digits, basically. So like I say, we're not unhappy with where we are in the bigger picture on how our plan is trending, even with the large claim activity this recent period.

Jim Macdonald -- First Analysis -- Analyst

Great. Thanks. That's why I wanted to ask.

Operator

Your next question comes from the line of Mark Marcon from Baird. Your line is open.

Mark Marcon -- Robert W. Baird & Co. -- Analyst

Just a couple of quick follow-ups. One, your existing clients, when do they receive the notification for what their rates are going to be for next year?

Paul J. Sarvadi -- Management Director, Chairman and Chief Executive Officer

Well, as you know or you may be aware, Mark, we are renewing clients every month of the year. There is a trend to that because we sell clients and they have an annual contract. We're selling every month. So people are renewing every month.

Now, at the year-end, we have about 40% to -- a little over 40% of our book of business renews in this January to February time period. And those we've -- we are well into renewing those accounts already -- or are actually a little ahead on that. But those -- the pricing on those accounts goes out in October, typically, the bulk of it, and so we are already out there renewing those accounts.

Mark Marcon -- Robert W. Baird & Co. -- Analyst

And are you renewing at roughly a 3.7% price increase for the -- for healthcare? Or how are you -- how do you price that?

Paul J. Sarvadi -- Management Director, Chairman and Chief Executive Officer

Yeah, this is what I was saying a little bit earlier. Let me try to be a little more clear with that. We actually are building in price increases that would be greater than that 3.7%, and that's -- on an individual account basis, we're looking at their specific experience in the total PEO relationship, not just the healthcare side, but within the allocation that we build in for the benefits. There would be an allocation increase above the 3.7%.

But what happens then is customers also have options to change the plan they selected or change the contributions they're making and so forth between the client and employees. So there's other decisions that are made. And once we get on any renewal period, whether it's the month or the year-end, once we -- reenroll and pay everybody or we renew them and pay them under the new system, their total increase in benefit allocation can be less than that number that we built in because they may have made a change in the plan.

So we would anticipate -- our best guess would be around a 3% increase that came from pricing. But then of course you have to realize that would have been driven by going to lower cost plans that would offset the trend that we're talking about that occurred this year, the 3.7%. So, all in, like I say, our pricing compared to our all-in cost is still well intact, not an issue there that has driven a big change in pricing strategy.

Does that help any?

Mark Marcon -- Robert W. Baird & Co. -- Analyst

It does. I was just wondering how does that compare. Like, if a client has been with you for, say, three years, the price increase that they're looking at this year for like-for-like insurance plan, how does that compare to like the price increase that they would have seen last year?

Paul J. Sarvadi -- Management Director, Chairman and Chief Executive Officer

Yeah, that's a good question. It wouldn't be -- it would be a little bit higher, maybe 1% higher than they would have seen a year ago because we would have been -- as this year has gone on, we have been moderately raising pricing to reflect what's been happening in the underlying plan, not so much related to the large claims but just to the normal trend that you look at.

Now, for example, pharmacy trend has been a little elevated over the course of the year. So those kind of things get factored in. But the good -- the thing to remember is that the longer a client is with us, the more they have had multiple years of lower than market increases in benefit plans and the better this deal gets for our clients. That's the reality of them.

Mark Marcon -- Robert W. Baird & Co. -- Analyst

And what's the typical client churn that you would expect during this core time period?

Paul J. Sarvadi -- Management Director, Chairman and Chief Executive Officer

I'm sorry, typical what trend?

Mark Marcon -- Robert W. Baird & Co. -- Analyst

Client churn that you would typically [Speech Overlap].

Paul J. Sarvadi -- Management Director, Chairman and Chief Executive Officer

Client churn?

Mark Marcon -- Robert W. Baird & Co. -- Analyst

Yes.

Paul J. Sarvadi -- Management Director, Chairman and Chief Executive Officer

Okay. Yeah. So, our annual attrition in clients is typically the last five years now been around 15% -- 14% to 16%. So let's call it 15%. And the way that has played out over the last five years, it's more like a 6% to 8% that go away in January because you have such a high percentage of customers renewing. And then you have less than -- you probably have a 2% to 3% for February and then you have a 0.5% to 0.7% every month thereafter. So that's kind of your trend -- I mean, that's the pattern of how you get to about 15%.

Mark Marcon -- Robert W. Baird & Co. -- Analyst

Okay. And then the BPA productivity typically around this time of the year?

Paul J. Sarvadi -- Management Director, Chairman and Chief Executive Officer

Well, this is when it really bumps up. This is when you really work hard to have as many BPAs trained as possible and running at a good efficiency level and get them as many qualified leads as possible. So we usually, in our fall campaign, we typically have nearly double the -- or about maybe 1.7% or 1.8% over what you had in the first and second quarter, for example. So it's -- this is making hay while the sun is out.

Mark Marcon -- Robert W. Baird & Co. -- Analyst

Okay, great. Look forward to talking offline as well. Thank you.

Paul J. Sarvadi -- Management Director, Chairman and Chief Executive Officer

Absolutely. Thank you for your questions.

Operator

There are no further questions at this time. I'd now like to turn the call back over to your presenters.

Paul J. Sarvadi -- Management Director, Chairman and Chief Executive Officer

Well, once again, thank you, all, for joining us today. We appreciate your interest and we look forward to having better news for us next quarter and we're going to finish off this year strong with a good fall campaign and look forward to a strong 2020. Thank you for joining us.

Operator

[Operator Closing Remarks]

Duration: 44 minutes

Call participants:

Douglas S. Sharp -- Senior Vice President-Finance, Chief Financial Officer and Treasurer

Paul J. Sarvadi -- Management Director, Chairman and Chief Executive Officer

Jasper Bibb -- SunTrust Robinson Humphrey -- Analyst

Jim Macdonald -- First Analysis -- Analyst

Jeff Martin -- Roth Capital Partners -- Analyst

Mark Marcon -- Robert W. Baird & Co. -- Analyst

More NSP analysis

All earnings call transcripts

AlphaStreet Logo